Publication | Closed Access
2009 SAFETY AND ANTIVIRAL ACTIVITY OF ANA598 IN COMBINATION WITH PEGYLATED INTERFERON α2A PLUS RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 CHRONIC HCV PATIENTS
41
Citations
0
References
2010
Year
Viral HepatitisImmunologyAntiviral Drug DevelopmentHepatitisVirologyAntiviral TherapyAntiviral DrugMedicineAntiviral CompoundViral Immunity
No additional data available for this publication yet. Check back later!